NVS Novartis AG Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
12:20
Sep 17
Sep 17
r/wallstreetbets
Long NVS for dividend despite trial failures
The author holds Novartis as a long-term investment, citing its scale as a major pharma player and a 3.4% dividend as a cash incentive to stay invested. The stated risks are three major drug trials halted for ineffectiveness and big drugs coming off patent. No specific catalyst or time horizon beyond 'long-term' is given.
NVS
Novartis AG
Long
1ST
—
—
12:33
Sep 09
Sep 09
Bloomberg Markets
Novartis pipeline setbacks keep pressuring stock.
Novartis suffered its third disappointing drug trial result in a week, with a late-stage neuromuscular candidate missing its primary endpoint, so the stock's decline is likely to continue.
NVS
Novartis AG
Avoid
—
—
22:00
Sep 08
Sep 08
3PRO TV
Avoid Novartis and Amgen on failures
Novartis fell 14% after three clinical failures in a week, including pelacarsen failing to reduce cardiovascular events despite lowering cholesterol. Amgen is trading down because it is testing a similar mechanism, implying downside pressure on comparable names.
NVS
Novartis AG
Avoid
—
—
About NVS Investor Commentary
Across the available history and selected sources, Buzzberg tracks NVS (Novartis AG) across 17 sources: 18 bullish vs 1 bearish calls from 32 authors. Historical directional balance: 25% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 68 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: u/Nearby_Valuable_5467, Olivia Levy, Park Myung-seok.